Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.64SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.5.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KP.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.11.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JD.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.32.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HK.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.8.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDRSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.54SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.196SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.57SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.459SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.117SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.381SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.237SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.382SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.395SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FW.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used